|
WO2009070650A1
(en)
*
|
2007-11-26 |
2009-06-04 |
The Research Foundation Of State University Of New York |
Small molecule cancer treatments that cause necrosis in cancer cells but do not affect normal cells
|
|
WO2010044894A1
(en)
|
2008-10-15 |
2010-04-22 |
4S3 Bioscience Inc. |
Methods and compositions for treatment of myotonic dystrophy
|
|
US9155801B2
(en)
|
2009-05-28 |
2015-10-13 |
The United States Government As Represented By The Department Of Veterans Affairs |
Amino acid sequences which enhance peptide conjugate solubility
|
|
BRPI1011236A2
(pt)
|
2009-06-15 |
2019-07-09 |
4S3 Bioscience Inc |
métodos e composições para tratamento de miopatia miotubular usando polipeptídeos quiméricos compreendendo polipeptídeos miotubularesih 1 (mtm1)
|
|
ES2744840T3
(es)
|
2011-04-01 |
2020-02-26 |
Univ Yale |
Anticuerpos anti-ADN que penetran en las células y usos de los mismos para inhibir la reparación del ADN
|
|
JP2014512184A
(ja)
*
|
2011-04-07 |
2014-05-22 |
メモリアル スローン−ケタリング キャンサー センター |
抗腫瘍抗体−腫瘍抑制因子融合タンパク質組成物およびがんの処置のための使用方法
|
|
WO2013138662A1
(en)
|
2012-03-16 |
2013-09-19 |
4S3 Bioscience, Inc. |
Antisense conjugates for decreasing expression of dmpk
|
|
US12195550B2
(en)
|
2012-03-30 |
2025-01-14 |
The United States Of America As Represented By The Department Of Veterans Affairs |
Targeting intracellular target-binding determinants with intracellular antibodies
|
|
US9283272B2
(en)
*
|
2012-03-30 |
2016-03-15 |
The United States Of America As Represented By The Department Of Veterans Affairs |
Targeting intracellular target-binding determinants with intracellular antibodies
|
|
US20150152170A1
(en)
*
|
2012-05-23 |
2015-06-04 |
Valerion Therapeutics, Llc |
Methods for increasing muscle contractility
|
|
WO2014130723A1
(en)
|
2013-02-20 |
2014-08-28 |
Valerion Therapeutics, Llc |
Methods and compositions for treatment of pompe disease
|
|
CA2936102A1
(en)
|
2014-01-13 |
2015-07-16 |
Valerion Therapeutics, Llc |
Internalizing moieties
|
|
WO2015134607A1
(en)
|
2014-03-04 |
2015-09-11 |
Yale University |
Cell penetrating anti-guanosine antibody based therapy for cancers with ras mutations
|
|
US10238742B2
(en)
|
2014-06-25 |
2019-03-26 |
Yale University |
Cell penetrating nucleolytic antibody based cancer therapy
|
|
EP3186278A4
(en)
|
2014-08-27 |
2018-04-04 |
Valerion Therapeutics, LLC |
Internalizing moieties for treatment of cancer
|
|
US10709761B2
(en)
|
2015-10-08 |
2020-07-14 |
University Of Utah Research Foundation |
Methods and compositions for preventing or treating cancer
|
|
US11016085B2
(en)
|
2016-04-25 |
2021-05-25 |
The Johns Hopkins University |
ZNT8 assays for drug development and pharmaceutical compositions
|
|
US12486318B2
(en)
|
2016-06-15 |
2025-12-02 |
Yale University |
Anti-guanosine antibody as a molecular delivery vehicle
|
|
WO2017218825A1
(en)
|
2016-06-15 |
2017-12-21 |
Yale University |
Antibody-mediated autocatalytic, targeted delivery of nanocarriers to tumors
|
|
EP3652540A4
(en)
|
2017-07-12 |
2021-04-07 |
The Johns Hopkins University |
PROTEOLIPOSOME BASED ZNT-8 SELF-ANTIGENT FOR THE DIAGNOSIS OF TYPE 1 DIABETES
|
|
WO2019152806A1
(en)
*
|
2018-02-01 |
2019-08-08 |
Yale University |
Compositions and methods for enhancing nuclear translocation
|
|
WO2019195851A1
(en)
|
2018-04-06 |
2019-10-10 |
Oncolyze, Inc. |
Compositions for use in lysis of selective cancer cells
|
|
WO2020037174A1
(en)
|
2018-08-16 |
2020-02-20 |
The Johns Hopkins University |
Antibodies to human znt8
|
|
EP3844287B1
(en)
|
2018-08-31 |
2024-05-22 |
Yale University |
Compositions and methods for enhancing donor oligonucleotide-based gene editing
|
|
US12485180B2
(en)
|
2019-08-30 |
2025-12-02 |
Yale University |
Compositions and methods for delivery of nucleic acids to cells
|
|
US12366570B2
(en)
|
2019-10-01 |
2025-07-22 |
The Johns Hopkins University |
Cell-based ZNT8 assay
|
|
US20250129153A1
(en)
*
|
2021-08-20 |
2025-04-24 |
The Johns Hopkins University |
Cell-surface antibody to a specific biomarker of pancreatic beta-cells
|